欧洲心律管理设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

欧洲心律管理设备市场按产品(除颤器、起搏器和心脏再同步治疗设备)和地理划分

市场快照

cardiac rhythm management devices market
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计欧洲心律管理设备市场在预测期内的复合年增长率为 4.5%。由于心血管疾病患病率的增加、技术的进步以及用于心脏监测的门诊和家庭服务的使用增加,市场已经显示出持续增长。

心血管疾病患病率的增加是推动心律管理设备市场的主要因素之一。根据 2017 年欧洲心血管疾病统计,每年心血管疾病 (CVD) 在欧洲造成约 390 万人死亡,在欧盟 (EU) 造成超过 180 万人死亡。因此,心血管疾病在男性和女性中的发生率几乎相同。

随着欧洲老龄化人口的增加,许多患有心律失常的患者可能会增加,这是一个令人担忧的问题。产品交付方面也有技术创新,预计产品创新将见证强劲增长。

报告范围

根据报告的范围,心律管理是电生理学的一部分,用于管理心脏的功能。过去十年观察到心律管理设备的持续发展和使用,包括心脏再同步治疗、起搏器、植入式心脏复律除颤器和循环记录器。全科医生 (GP) 越来越多地参与使用这些设备对患者进行随访和管理。

By Product
Defibrillators
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators (ED)
Pacemakers
Implantable Pacemakers (ICPS)
External Pacemakers
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

主要市场趋势

除颤器部分预计将在预测期内占据主要份额

除颤器是一种通过向心脏发送电脉冲或电击来恢复正常心跳的医疗设备。该设备用于治疗心脏疾病,例如心律失常、心跳不均匀或过慢或过快。由于除颤器在治疗心脏骤停方面的功效,除颤器的使用正在增加。

根据 2017 年欧洲心血管疾病统计,心血管疾病 (CVD) 占欧洲所有死亡人数的 45%,占欧盟 (EU) 所有死亡人数的 37%。此外,中欧和东欧的缺血性心脏病 (IHD) 和中风死亡率普遍高于北欧、南欧和西欧。此外,随着发达经济体的政府一直致力于使国家对心脏更加友好,体外除颤器的市场也在扩大,这改善了除颤器在单一和多专科医院的使用。

Europe key trend 1.png

竞争格局

欧洲心律管理设备市场竞争激烈,由几个主要参与者组成。雅培、Abiomed、Biotronik SE & Co KG、Boston Scientific Corporation、Koninklijke Philips NV、LivaNova Plc、Medtronic PLC、SchillerAG、深圳迈瑞生物医学电子有限公司等公司在心律管理设备中占有相当大的市场份额市场地域扩张、合作、并购和新产品开发是心律管理设备市场参与者的一些关键任务。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Cardiovascular Disorders

      2. 4.2.2 Technological Advancements

      3. 4.2.3 Rise in the Use of Ambulatory and Home Services for Cardiac Monitoring

    3. 4.3 Market Restraints

      1. 4.3.1 Effects of Therapeutic Radiation on Implantable Cardiac Rhythm Devices

      2. 4.3.2 High Cost of Devices

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Defibrillators

        1. 5.1.1.1 Implantable Cardioverter Defibrillators (ICDS)

        2. 5.1.1.2 External Defibrillators (ED)

      2. 5.1.2 Pacemakers

        1. 5.1.2.1 Implantable Pacemakers (ICPS)

        2. 5.1.2.2 External Pacemakers

      3. 5.1.3 Cardiac Resynchronization Therapy Devices

        1. 5.1.3.1 Cardiac Resynchronization Therapy Defibrillators (CRT-D)

        2. 5.1.3.2 Cardiac Resynchronization Therapy Pacemakers (CRT-P)

    2. 5.2 Geography

      1. 5.2.1 Europe

        1. 5.2.1.1 Germany

        2. 5.2.1.2 United Kingdom

        3. 5.2.1.3 France

        4. 5.2.1.4 Italy

        5. 5.2.1.5 Spain

        6. 5.2.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Biotronik SE & Co KG

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 LivaNova Plc

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 SchillerAG

      8. 6.1.8 Shenzhen Mindray Biomedical Electronics Co., Ltd

      9. 6.1.9 Zoll Medical Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Cardiac Rhythm Management Devices Market market is studied from 2018 - 2026.

The Europe Cardiac Rhythm Management Devices Market is growing at a CAGR of 4.5% over the next 5 years.

Abbott Laboratories, Medtronic PLC, Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV are the major companies operating in Europe Cardiac Rhythm Management Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!